RJA
AMGN icon

Ross\Johnson & Associates’s Amgen AMGN Stock Holding History

Ross\Johnson & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Sell
300
-1
-0.3% -$356 1.9% 8
2025
Q4 		$98.5K Buy
301
+1
+0.3% +$317 1.83% 13
2025
Q3 		$84.7K Hold
300
– – 1.6% 12
2025
Q2 		$83.8K Hold
300
– – 1.72% 10
2025
Q1 		$93.5K Hold
300
– – 1.6% 9
2024
Q4 		$78.2K Buy
+300
New +$89K 1.81% 6

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ross\Johnson & Associates's AMGN Position: Q1 2026 in Review

Ross\Johnson & Associates reduced its Amgen (AMGN) stake by 0.33% in Q1 2026, selling an estimated $356 and leaving 300 shares worth $106K. The position accounts for 1.9% of the portfolio, ranked #8.

Ross\Johnson & Associates first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Ross\Johnson & Associates held 300 shares of Amgen worth $106K as of Q1 2026.
  • Ross\Johnson & Associates sold 1 Amgen share in Q1 2026, an estimated $356.
  • Amgen made up 1.9% of Ross\Johnson & Associates's portfolio in Q1 2026, its #8 holding.
  • Ross\Johnson & Associates first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.